Aspira Women's Health Inc. held its annual meeting of stockholders on June 4, 2025. The stockholders elected six nominees for director. An amendment to the 2019 Stock Incentive Plan was approved, increasing the number of shares authorized for grant. The issuance of warrants to purchase shares of common stock was also approved.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.